Key result
Serum cholesterol predicts 14-year CHD risk, while prebeta lipoprotein outperforms cholesterol in older women.
Cohort (n=5,127)
Answers are grounded in this paper and cite their sources.
Risk of coronary heart disease over 14 years was examined prospectively in 2,282 men and 2,845 women according to their antecedent cholesterol and lipoprotein status. An increased risk proportional to antecedent serum cholesterol was found whether or not it was associated with elevated Sf20-400 prebeta lipoprotein. When adjustment was made for the concomitant prebeta lipoprotein concentration and other factors related both to coronary heart disease risk and to blood lipids, a residual gradient of coronary heart disease risk proportional to the serum cholesterol was still evident. On the other hand, when risk of coronary heart disease was examined according to prebeta lipoprotein concentration, adjusting for cholesterol, no residual risk gradient remained in men. In women over 50, however, prebeta lipoprotein was superior to cholesterol in discriminating potential coronary heart disease cases. Risk of coronary heart disease in men can be estimated using any of the lipids evaluated: however, none proved more useful than an accurate total serum cholesterol.
No takes yet. Share an insight, caveat, or question.
William B. Kannel (1971) conducted a cohort in Coronary heart disease (n=5,127). Antecedent serum cholesterol and Sf20-400 prebeta lipoprotein vs. Lower cholesterol or prebeta lipoprotein concentrations was evaluated on Risk of coronary heart disease. Antecedent serum cholesterol predicted 14-year coronary heart disease risk in 5,127 adults, while Sf20-400 prebeta lipoprotein was superior to cholesterol in women over 50.
Synapse has enriched 10 related papers. Consider them for comparative context: